Prostatic neoplasms

Effect of estradiol on cognition in men undergoing androgen deprivation therapy: A randomized placebo-controlled trial

Authors: Nicholas Russell, James Allebone, Orwa Dandash, Rudolf Hoermann, Ada S Cheung, Jeffrey D Zajac, David J Handelsman, Richard A Kanaan, Mathis Grossmann

Journal: Clinical Endocrinology

Year Published: 2022

Objective: Roles for estradiol in modulating cognition in men remain uncertain. We assessed the isolated effects of estradiol on cognition in men in the absence of testosterone. Design: Randomized trial of transdermal estradiol 0.9 mg daily, […]

Results of a Real-world Study of Enzalutamide and Abiraterone Acetate With Prednisone Tolerability (REAAcT)

Authors: Neal D. Shore, Daniel Saltzstein, Paul Sieber, Bryan Mehlhaff, Lawrence Gervasi, Jennifer Phillips, Yu-Ning Wong, Huiling Pei, Tracy McGowan

Journal: Clinical Genitourinary Cancer

Year Published: 2019

Background: The objective of this study was to evaluate differences in tolerability in patients with metastatic castration-resistant prostate cancer treated with enzalutamide (ENZA) or abiraterone acetate plus prednisone (AA+P). Patients and Methods: This was a phase […]

Back to Publications